Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article published in Managed Healthcare Executive covers the results of its annual pharmacy survey and references the biosimilars approval tracker on the Center for Biosimilars® website, which lists how many biosimilars have been approved and their product launches worldwide.
A piece by Advisory Board referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Endoscopic Procedure May Eliminate Need for Insulin in Type 2 Diabetes,” discussed the beginning of work on a double-blind randomized controlled trial that would test the results of a preliminary study that found a 1-hour endoscopic procedure could eliminate the need for insulin in patients with type 2 diabetes.
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
Health Equity Conversations: Managing Underserved Communities and Value-Based Payment
May 23rd 2023On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Listen
Imetelstat Prolongs Transfusion Independence, Increases Hemoglobin in R/R MDS
June 8th 2023Treatment with the first-in-class direct and competitive telomerase inhibitor imetelstat resulted in statistically significant and clinically meaningful efficacy in patients with heavily transfusion dependent, non-del(5q) lower-risk myelodysplastic syndrome that is relapsed or refractory to erythropoiesis stimulating agents, according to findings from the phase 3 IMerge trial.
Read More
2 Clarke Drive
Cranbury, NJ 08512